What Are the NMPA’s Specific Requirements for Peptide Immunogenicity Studies?
The NMPA requires a risk-based, multi-tiered approach to assess peptide immunogenicity, ensuring patient safety and therapeutic efficacy.
HRTioAugust 3, 2025